search
Back to results

Oral Supplement for Pregnant and Lactating Mothers

Primary Purpose

Diarrhea, Acute Respiratory Infection

Status
Completed
Phase
Not Applicable
Locations
Philippines
Study Type
Interventional
Intervention
milk supplement 1
milk supplement 2
Sponsored by
Société des Produits Nestlé (SPN)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Diarrhea focused on measuring pregnancy, lactation, oral supplement, probiotics, early infections

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Expecting mothers who are in their 6th month of pregnancy
  • Willing to consume 2 x 200 ml of test product daily
  • Willing to exclusively breastfeed until the baby is at least 2-month old
  • Having signed the informed consent

Exclusion Criteria:

  • Known allergy to cow's milk
  • Subjects previously diagnosed HIV(+) and Hepatitis B (+)
  • Multiple pregnancy
  • High risk pregnancy (pre-eclampsia, diabetes, etc)
  • Currently participating or having participated in another clinical trial during the last 3 months
  • Subjects who consumed pro- and /or prebiotics-containing food/supplement* in the month before inclusion

Sites / Locations

  • Ospital Ng Muntinlupa

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

No Intervention

Arm Label

oral supplement1

oral supplement 2

Reference

Arm Description

Oral supplement for pregnant and lactating mothers

Oral supplement for pregnant and lactating mothers

No oral supplementation during pregnancy and lactating.

Outcomes

Primary Outcome Measures

The incidence of diarrhea in infants from birth to 1 year

Secondary Outcome Measures

In infants: growth, morbidity, immune maturation, metabolomics profile
In mothers: fetal growth, general health, immune system, metabolomics profile and preterm delivery

Full Information

First Posted
February 17, 2010
Last Updated
September 25, 2012
Sponsor
Société des Produits Nestlé (SPN)
Collaborators
University of the Philippines
search

1. Study Identification

Unique Protocol Identification Number
NCT01073033
Brief Title
Oral Supplement for Pregnant and Lactating Mothers
Official Title
Oral Supplement for Pregnant and Lactating Mothers to Promote Infant Immune Maturation and Protection Against Early Life Infections
Study Type
Interventional

2. Study Status

Record Verification Date
September 2012
Overall Recruitment Status
Completed
Study Start Date
April 2010 (undefined)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
August 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Société des Produits Nestlé (SPN)
Collaborators
University of the Philippines

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To assess protection against early life infections through supplementation of mothers during pregnancy to the newborns' growth, morbidity, immune status intra and extra-uterine.
Detailed Description
During pregnancy mothers have to fulfill the tremendous physiological needs to support their own immune status as well as that of their babies. Accordingly, it appears highly valuable to provide mothers with a nutritional supplement during pregnancy and lactation to promote the immune development in newborns, thus reinforcing the infants' defenses. In that respect, an appropriate maternal diet must provide sufficient energy and nutrients to meet the mother's usual requirements and promote health status, as well as the needs of the growing fetus and beyond for the neonate. Key organogenesis steps take place during fetal life and many functional features of the immune system are already coded in the genetic asset of the individual. However, at birth the immune system remains fairly immature. An epigenetic, postnatal instruction seems to be extremely important for the maturation of the immune system allowing its full functionality. The cross-talk between the mother and her baby is, indeed, crucial for the optimal development of the foetus and subsequently for the full and functional maturation of the neonate. The newborn relies for his protection almost exclusively on his innate immune system that is initially instructed and educated early in life by factors derived from his mother as well as post-natal environmental factors such as early life colonization with micro-organisms that activates the innate immunity and enhance Th1-cell polarization thereby potentially reducing atopic dermatitis with respect to the hygiene hypothesis. A large part of this immune education is provided by factors transmitted from the mother pre-natally through the placenta or post-natally via the breast milk. Breast milk contains a number of nutrients and bioactive components, including immune cells, maternal antibodies (mainly secretory IgA), cytokines, growth factors, lactoferrin, nucleotides, triacylglycerols, fatty acids, oligosaccharides, and vitamins. All together, these components beneficially impact the health status of the newborn, conferring, among other functions, immune education and early protection. A typical example of such transfer of immune competence is the TGF-β that could be transmitted in active from either through the placenta or absorbed by the neonates through the milk. This TGF-β is an important IgA switch factor and this is likely to be responsible, in part, for the capacity of breast-fed infant to produce higher levels of mucosal SIgA compared to non-breast fed infants. Moreover, milk soluble CD14 transmitted to the newborn contributes to prime the neonatal gut to modulate the microbial recognition and establishment of endogenous microbiota. Diarrhea episodes are major manifestation of common infant infections of viral or bacterial aetiology and are a key health concern in paediatrics. As mentioned above there are evidences that some probiotic strains significantly improve diarrheal outcomes in infants, particularly rotavirus diarrhea. In that respect diarrhea occurrence was selected as the primary outcome in the present trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diarrhea, Acute Respiratory Infection
Keywords
pregnancy, lactation, oral supplement, probiotics, early infections

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
234 (Actual)

8. Arms, Groups, and Interventions

Arm Title
oral supplement1
Arm Type
Experimental
Arm Description
Oral supplement for pregnant and lactating mothers
Arm Title
oral supplement 2
Arm Type
Active Comparator
Arm Description
Oral supplement for pregnant and lactating mothers
Arm Title
Reference
Arm Type
No Intervention
Arm Description
No oral supplementation during pregnancy and lactating.
Intervention Type
Dietary Supplement
Intervention Name(s)
milk supplement 1
Other Intervention Name(s)
Suitable for pregnant and lactating period.
Intervention Description
milk supplement with probiotics
Intervention Type
Dietary Supplement
Intervention Name(s)
milk supplement 2
Other Intervention Name(s)
Suitable for pregnant and lactating periode.
Intervention Description
milk supplement without probiotics
Primary Outcome Measure Information:
Title
The incidence of diarrhea in infants from birth to 1 year
Time Frame
24 months
Secondary Outcome Measure Information:
Title
In infants: growth, morbidity, immune maturation, metabolomics profile
Time Frame
18 months
Title
In mothers: fetal growth, general health, immune system, metabolomics profile and preterm delivery
Time Frame
18 months

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Expecting mothers who are in their 6th month of pregnancy Willing to consume 2 x 200 ml of test product daily Willing to exclusively breastfeed until the baby is at least 2-month old Having signed the informed consent Exclusion Criteria: Known allergy to cow's milk Subjects previously diagnosed HIV(+) and Hepatitis B (+) Multiple pregnancy High risk pregnancy (pre-eclampsia, diabetes, etc) Currently participating or having participated in another clinical trial during the last 3 months Subjects who consumed pro- and /or prebiotics-containing food/supplement* in the month before inclusion
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr. Valerie Guinto, MD
Organizational Affiliation
University of the Philippines
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Dr. Jacinto Mantaring, MD
Organizational Affiliation
University of the Philippines
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ospital Ng Muntinlupa
City
Manila
Country
Philippines

12. IPD Sharing Statement

Citations:
PubMed Identifier
29855271
Citation
Mantaring J, Benyacoub J, Destura R, Pecquet S, Vidal K, Volger S, Guinto V. Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines. BMC Pregnancy Childbirth. 2018 May 31;18(1):193. doi: 10.1186/s12884-018-1828-8.
Results Reference
derived

Learn more about this trial

Oral Supplement for Pregnant and Lactating Mothers

We'll reach out to this number within 24 hrs